Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, Schermer TR, Biermans MC.

Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15.

PMID:
29335324
2.

Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Con Side of the Argument.

Deinum J, Prejbisz A, Lenders JWM, van der Wilt GJ.

Hypertension. 2018 Jan;71(1):10-14. doi: 10.1161/HYPERTENSIONAHA.117.09294. No abstract available.

PMID:
29229748
3.

Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review.

Velema MS, de Nooijer AH, Burgers VWG, Hermus ARMM, Timmers HJLM, Lenders JWM, Husson O, Deinum J.

Horm Metab Res. 2017 Dec;49(12):943-950. doi: 10.1055/s-0043-121706. Epub 2017 Dec 4.

PMID:
29202493
4.

Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.

Velema M, Dekkers T, Hermus A, Timmers H, Lenders J, Groenewoud H, Schultze Kool L, Langenhuijsen J, Prejbisz A, van der Wilt GJ, Deinum J; SPARTACUS investigators.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):16-24. doi: 10.1210/jc.2017-01442.

PMID:
29099925
5.

Patient characteristics do not predict the individual response to antihypertensive medication: a cross-over trial.

van der Wel MC, Biermans M, Akkermans R, Lenders JWM, van Weel C, Deinum J.

Fam Pract. 2018 Jan 16;35(1):67-73. doi: 10.1093/fampra/cmx075.

PMID:
28968870
6.

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.

Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.

7.

Adrenal Vein Catecholamine Levels and Ratios: Reference Intervals Derived from Patients with Primary Aldosteronism.

Sze CWC, O'Toole SM, Tirador RK, Akker SA, Matson M, Perry L, Druce MR, Dekkers T, Deinum J, Lenders JWM, Eisenhofer G, Drake WM.

Horm Metab Res. 2017 Jun;49(6):418-423. doi: 10.1055/s-0042-124419. Epub 2017 Apr 26.

PMID:
28445897
8.

Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism.

Arlt W, Lang K, Sitch AJ, Dietz AS, Rhayem Y, Bancos I, Feuchtinger A, Chortis V, Gilligan LC, Ludwig P, Riester A, Asbach E, Hughes BA, O'Neil DM, Bidlingmaier M, Tomlinson JW, Hassan-Smith ZK, Rees DA, Adolf C, Hahner S, Quinkler M, Dekkers T, Deinum J, Biehl M, Keevil BG, Shackleton CHL, Deeks JJ, Walch AK, Beuschlein F, Reincke M.

JCI Insight. 2017 Apr 20;2(8). pii: 93136. doi: 10.1172/jci.insight.93136. [Epub ahead of print]

9.

Plasma galectin-3 concentrations in patients with primary aldosteronism.

van den Berg TNAD, Meijers WC, Donders ART, Van Herwaarden AE, Rongen GA, de Boer RA, Deinum J, Riksen NP.

J Hypertens. 2017 Sep;35(9):1849-1856. doi: 10.1097/HJH.0000000000001383.

PMID:
28403043
10.

A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence.

Makai P, IntHout J, Deinum J, Jenniskens K, Wilt GJV.

J Gen Intern Med. 2017 Aug;32(8):921-930. doi: 10.1007/s11606-017-4000-7. Epub 2017 Mar 8.

11.

Hydrochlorothiazide treatment increases the abundance of the NaCl cotransporter in urinary extracellular vesicles of essential hypertensive patients.

Pathare G, Tutakhel OAZ, van der Wel MC, Shelton LM, Deinum J, Lenders JWM, Hoenderop JGJ, Bindels RJM.

Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F1063-F1072. doi: 10.1152/ajprenal.00644.2016. Epub 2017 Mar 8.

PMID:
28274929
12.

Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.

Jönsson Rylander AC, Lindgren A, Deinum J, Bergström GM, Böttcher G, Kalies I, Wåhlander K.

J Thromb Haemost. 2017 Apr;15(4):758-769. doi: 10.1111/jth.13641. Epub 2017 Feb 28.

PMID:
28135035
13.

Congenital eyelid ptosis, decreased glomerular filtration, and orthostatic hypotension: Answers.

Wassenberg T, Willemsen M, Dijkman H, Deinum J, Monnens L.

Pediatr Nephrol. 2017 Jul;32(7):1171-1174. doi: 10.1007/s00467-016-3515-1. Epub 2016 Nov 17. No abstract available.

14.

Congenital eyelid ptosis, decreased glomerular filtration, and orthostatic hypotension: Questions.

Wassenberg T, Willemsen M, Dijkman H, Deinum J, Monnens L.

Pediatr Nephrol. 2017 Jul;32(7):1169-1170. doi: 10.1007/s00467-016-3494-2. Epub 2016 Nov 17. No abstract available.

15.

Adrenal vein sampling versus CT scanning in primary aldosteronism - Authors' reply.

van der Wilt GJ, Dekkers T, Lenders JW, Deinum J.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):886-887. doi: 10.1016/S2213-8587(16)30236-4. No abstract available.

PMID:
27793317
16.

Evaluating the learning curve for retroperitoneoscopic adrenalectomy in a high-volume center for laparoscopic adrenal surgery.

van Uitert A, d'Ancona FCH, Deinum J, Timmers HJLM, Langenhuijsen JF.

Surg Endosc. 2017 Jul;31(7):2771-2775. doi: 10.1007/s00464-016-5284-0. Epub 2016 Oct 17.

17.

Effects of Treating Primary Aldosteronism on Renal Function.

Kramers BJ, Kramers C, Lenders JW, Deinum J.

J Clin Hypertens (Greenwich). 2017 Mar;19(3):290-295. doi: 10.1111/jch.12914. Epub 2016 Sep 23.

18.

Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.

Dekkers T, Prejbisz A, Kool LJS, Groenewoud HJMM, Velema M, Spiering W, Kołodziejczyk-Kruk S, Arntz M, Kądziela J, Langenhuijsen JF, Kerstens MN, van den Meiracker AH, van den Born BJ, Sweep FCGJ, Hermus ARMM, Januszewicz A, Ligthart-Naber AF, Makai P, van der Wilt GJ, Lenders JWM, Deinum J; SPARTACUS Investigators.

Lancet Diabetes Endocrinol. 2016 Sep;4(9):739-746. doi: 10.1016/S2213-8587(16)30100-0. Epub 2016 Jun 17.

PMID:
27325147
19.

Total Knee Arthroplasty in Severe Synovial Osteochondromatosis in an Osteoarthritic Knee.

Deinum J, Nolte PA.

Clin Orthop Surg. 2016 Jun;8(2):218-22. doi: 10.4055/cios.2016.8.2.218. Epub 2016 May 10.

20.

Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.

Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, Hermus AR, Lenders JW, Deinum J.

J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35. doi: 10.1210/jc.2016-1472. Epub 2016 May 12. Review.

PMID:
27172433
21.

Eplerenone does not limit ischemia-reperfusion injury in human myocardial tissue.

van den Berg TN, van Swieten HA, Vos JC, Verweij V, Wouterse AC, Deinum J, Morshuis WJ, Rongen GA, Riksen NP.

Int J Cardiol. 2016 Aug 1;216:110-3. doi: 10.1016/j.ijcard.2016.04.150. Epub 2016 Apr 22. No abstract available.

22.

Central arteriovenous anastomosis and hypertension.

Deinum J, Wetzels JF.

Lancet. 2015 Nov 7;386(10006):1821. doi: 10.1016/S0140-6736(15)00760-6. No abstract available.

PMID:
26843305
23.

Safety and long-term effects of renal denervation: Rationale and design of the Dutch registry.

Sanders MF, Blankestijn PJ, Voskuil M, Spiering W, Vonken EJ, Rotmans JI, van der Hoeven BL, Daemen J, van den Meiracker AH, Kroon AA, de Haan MW, Das M, Bax M, van der Meer IM, van Overhagen H, van den Born BJ, van Brussel PM, van der Valk PH, Smak Gregoor PJ, Meuwissen M, Gomes ME, Oude Ophuis T, Troe E, Tonino WA, Konings CJ, de Vries PA, van Balen A, Heeg JE, Smit JJ, Elvan A, Steggerda R, Niamut SM, Peels JO, de Swart JB, Wardeh AJ, Groeneveld JH, van der Linden E, Hemmelder MH, Folkeringa R, Stoel MG, Kant GD, Herrman JP, van Wissen S, Deinum J, Westra SW, Aengevaeren WR, Parlevliet KJ, Schramm A, Jessurun GA, Rensing BJ, Winkens MH, Wierema TK, Santegoets E, Lipsic E, Houwerzijl E, Kater M, Allaart CP, Nap A, Bots ML.

Neth J Med. 2016 Jan;74(1):5-15.

24.

Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.

Eisenhofer G, Dekkers T, Peitzsch M, Dietz AS, Bidlingmaier M, Treitl M, Williams TA, Bornstein SR, Haase M, Rump LC, Willenberg HS, Beuschlein F, Deinum J, Lenders JW, Reincke M.

Clin Chem. 2016 Mar;62(3):514-24. doi: 10.1373/clinchem.2015.251199. Epub 2016 Jan 19.

25.

Steroid Hormone Production in Patients with Aldosterone Producing Adenomas.

Moors M, Williams TA, Deinum J, Eisenhofer G, Reincke M, Lenders JW.

Horm Metab Res. 2015 Dec;47(13):967-72. doi: 10.1055/s-0035-1565225. Epub 2015 Dec 14. Review.

PMID:
26667800
26.

Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas.

Williams TA, Peitzsch M, Dietz AS, Dekkers T, Bidlingmaier M, Riester A, Treitl M, Rhayem Y, Beuschlein F, Lenders JW, Deinum J, Eisenhofer G, Reincke M.

Hypertension. 2016 Jan;67(1):139-45. doi: 10.1161/HYPERTENSIONAHA.115.06186. Epub 2015 Nov 16.

27.

Alternative splice variant of the thiazide-sensitive NaCl cotransporter: a novel player in renal salt handling.

Tutakhel OA, Jeleń S, Valdez-Flores M, Dimke H, Piersma SR, Jimenez CR, Deinum J, Lenders JW, Hoenderop JG, Bindels RJ.

Am J Physiol Renal Physiol. 2016 Feb 1;310(3):F204-16. doi: 10.1152/ajprenal.00429.2015. Epub 2015 Nov 11.

28.

Network Meta-Analysis of Various Treatment Strategies in Resistant Hypertension.

Makai P, intHout J, Grutters JP, Deinum J, Jenniskens K, van der Wilt GJ.

Value Health. 2015 Nov;18(7):A377. doi: 10.1016/j.jval.2015.09.790. Epub 2015 Oct 20. No abstract available.

29.

[Primary aldosteronism: new insights into familial forms].

van den Meiracker AH, van der Linde AA, Claahsen van der Grinten HL, Danser AH, Deinum J.

Ned Tijdschr Geneeskd. 2015;159:A8932. Review. Dutch.

PMID:
26420144
30.

Influence of the hospital environment and presence of the physician on the white-coat effect.

Adiyaman A, Aksoy I, Deinum J, Staessen JA, Thien T.

J Hypertens. 2015 Nov;33(11):2245-9. doi: 10.1097/HJH.0000000000000691.

PMID:
26259118
31.

Pharmacological treatment of aldosterone excess.

Deinum J, Riksen NP, Lenders JW.

Pharmacol Ther. 2015 Oct;154:120-33. doi: 10.1016/j.pharmthera.2015.07.006. Epub 2015 Jul 26. Review.

PMID:
26213109
32.

Should blood pressure be measured with the cuff on a bare arm?

Thien T, Keltjens EB, Lenders JW, Deinum J.

Blood Press Monit. 2015 Dec;20(6):320-4. doi: 10.1097/MBP.0000000000000142.

PMID:
26192231
33.

The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: reply.

Hansson KM, Elg M, Deinum J.

J Thromb Haemost. 2015 Aug;13(8):1530-2. doi: 10.1111/jth.13029. Epub 2015 Jul 15. No abstract available.

34.

Higher outdoor temperatures are progressively associated with lower blood pressure: a longitudinal study in 100,000 healthy individuals.

van den Hurk K, de Kort WL, Deinum J, Atsma F.

J Am Soc Hypertens. 2015 Jul;9(7):536-43. doi: 10.1016/j.jash.2015.05.003. Epub 2015 May 11.

PMID:
26089227
35.

Serum creatinine levels during and after long-term treatment with cyclosporine A in patients with severe atopic dermatitis.

van der Schaft J, van Zuilen AD, Deinum J, Bruijnzeel-Koomen CA, de Bruin-Weller MS.

Acta Derm Venereol. 2015 Nov;95(8):963-7. doi: 10.2340/00015555-2125.

36.

Characterization of thrombin derived from human recombinant prothrombin.

Lövgren A, Deinum J, Rosén S, Bryngelhed P, Rosén P, Hansson KM.

Blood Coagul Fibrinolysis. 2015 Jul;26(5):545-55. doi: 10.1097/MBC.0000000000000289.

37.

Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.

Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS.

J Eur Acad Dermatol Venereol. 2015 Oct;29(10):1905-12. doi: 10.1111/jdv.13064. Epub 2015 Mar 9.

PMID:
25752497
38.

The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study.

van den Berg TN, Deinum J, Bilos A, Donders AR, Rongen GA, Riksen NP.

PLoS One. 2014 Oct 30;9(10):e111248. doi: 10.1371/journal.pone.0111248. eCollection 2014.

39.

An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism.

Peitzsch M, Dekkers T, Haase M, Sweep FC, Quack I, Antoch G, Siegert G, Lenders JW, Deinum J, Willenberg HS, Eisenhofer G.

J Steroid Biochem Mol Biol. 2015 Jan;145:75-84. doi: 10.1016/j.jsbmb.2014.10.006. Epub 2014 Oct 11.

PMID:
25312486
40.

Image Registration of Cone-Beam Computer Tomography and Preprocedural Computer Tomography Aids in Localization of Adrenal Veins and Decreasing Radiation Dose in Adrenal Vein Sampling.

Busser WM, Arntz MJ, Jenniskens SF, Deinum J, Hoogeveen YL, de Lange F, Schultze Kool LJ.

Cardiovasc Intervent Radiol. 2015 Aug;38(4):993-7. doi: 10.1007/s00270-014-0969-z. Epub 2014 Sep 20.

PMID:
25238715
41.

The effect of recombinant and plasma-derived prothrombin on prothrombin time in human plasma.

Hansson KM, Björkqvist J, Deinum J.

Int J Lab Hematol. 2015 Jun;37(3):357-64. doi: 10.1111/ijlh.12293. Epub 2014 Sep 12.

PMID:
25212252
42.

The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood.

Hansson KM, Nielsen S, Elg M, Deinum J.

J Thromb Haemost. 2014 Oct;12(10):1678-86. doi: 10.1111/jth.12707. Epub 2014 Sep 30.

43.

Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause?

Stunnenberg BC, Deinum J, Links TP, Wilde AA, Franssen H, Drost G.

Muscle Nerve. 2014 Sep;50(3):327-32. doi: 10.1002/mus.24225. Epub 2014 Aug 12.

PMID:
25088161
44.

[Is this the end for double RAAS inhibition?].

Deinum J.

Ned Tijdschr Geneeskd. 2014;158:A7346. Dutch.

PMID:
25027214
45.

Addition of prothrombin to plasma can result in a paradoxical increase in activated partial thromboplastin time.

Hansson KM, Björkqvist J, Deinum J.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):851-5. doi: 10.1097/MBC.0000000000000161.

PMID:
25004021
46.

Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

Dekkers T, ter Meer M, Lenders JW, Hermus AR, Schultze Kool L, Langenhuijsen JF, Nishimoto K, Ogishima T, Mukai K, Azizan EA, Tops B, Deinum J, Küsters B.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1341-51. doi: 10.1210/jc.2013-4255. Epub 2014 Apr 23.

PMID:
24758183
47.

Does wave reflection explain the increase in blood pressure during leg crossing?

van Velthoven MH, Holewijn S, van der Wilt GJ, Thien T, Deinum J.

Blood Press Monit. 2014 Jun;19(3):129-33. doi: 10.1097/MBP.0000000000000040.

PMID:
24608727
48.

The cardioprotective effects of mineralocorticoid receptor antagonists.

van den Berg TN, Rongen GA, Fröhlich GM, Deinum J, Hausenloy DJ, Riksen NP.

Pharmacol Ther. 2014 Apr;142(1):72-87. doi: 10.1016/j.pharmthera.2013.11.006. Epub 2013 Nov 23. Review.

PMID:
24275323
49.

Plasma metanephrine for assessing the selectivity of adrenal venous sampling.

Dekkers T, Deinum J, Schultzekool LJ, Blondin D, Vonend O, Hermus AR, Peitzsch M, Rump LC, Antoch G, Sweep FC, Bornstein SR, Lenders JW, Willenberg HS, Eisenhofer G.

Hypertension. 2013 Dec;62(6):1152-7. doi: 10.1161/HYPERTENSIONAHA.113.01601. Epub 2013 Sep 30.

50.

Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.

Jansen PM, van den Born BJ, Frenkel WJ, de Bruijne EL, Deinum J, Kerstens MN, Smulders YM, Woittiez AJ, Wijbenga JA, Zietse R, Danser AH, van den Meiracker AH.

J Hypertens. 2014 Jan;32(1):115-26. doi: 10.1097/HJH.0b013e3283656b54.

PMID:
24018605

Supplemental Content

Loading ...
Support Center